Enanta Pharmaceuticals's chart data is dated 2026-10-08. Recorded technical signals: Death cross. There are 1 published signal records.
Enanta Pharmaceuticals last closed at $12.10 (-2.18%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq. Trailing 12 months PER is -5.6×. Its overall grade ranks 466 of 738 stocks in Healthcare.
About this company
Enanta Pharmaceuticals last closed at $12.10 (-2.18%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 466/738
Valuation grade B+
Related stocks
- AbbVieCustomer
과거 주요 로열티/협업 파트너로, Enanta의 C형간염 관련 수익과 연결된 핵심 고객·협력사
- Vertex PharmaceuticalsCompetitor
호흡기/항바이러스 및 질환 치료제 개발에서 파이프라인이 일부 겹치는 대표 경쟁사
- Gilead SciencesCompetitor
항바이러스 치료제 영역의 대형 경쟁사로, 감염질환 시장에서 직접 비교되는 기업
About Enanta Pharmaceuticals
- What technical signals does Enanta Pharmaceuticals (ENTA) have?
- Enanta Pharmaceuticals current technical signals: death cross (5_20, 0d ago).
- Is Enanta Pharmaceuticals a cup-and-handle pattern?
- No. Enanta Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Enanta Pharmaceuticals?
- Market cap: $349.24M. Trailing 12 months PER: -5.6×. Latest quarter PBR: 3.48×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Enanta Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.